Register
CBT More Cost Effective than Meds in the Long Run? |
Journal Updates
eMediNexus Coverage from: 
CBT More Cost Effective than Meds in the Long Run?
eMediNexus,  04 November 2019
remove_red_eye 496 Views
#Neurology #Pharmacist #Psychiatry

0 Read Comments                

Cognitive behavioral therapy (CBT) for major depression appears to be slightly more cost effective than treatment with second-generation antidepressants (SGAs) in the long run and shows equivalent, or even superior, efficacy.

Results from a meta-analysis, as well as additional clinical and economic data, show that SGAs for major depressive disorder (MDD) were 70% more likely to be cost effective at 1 year, while CBT was 75% more likely to be cost effective at 5 years with a suggested efficacy advantage. The study was published online October 28 in the Annals of Internal Medicine.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now